LLX Solutions LLC is a biopharmaceutical services company with a mission to provide clinical trial design, protocol development, statistical analysis, programming, data management, and consulting services to the pharmaceutical, biotechnology, and medical device industries. With a focus on global clinical trials in various therapeutic categories such as cardiology, oncology, rare disease, medical devices, and more, the company's team boasts over 12 years of experience in the industry and a proven track record of working with renowned companies such as Wyeth/Pfizer, Shire, Genzyme, Altus, Ariad, Synta, Boston Scientific, among others. Founded in 2011 and headquartered in Waltham, Massachusetts, LLX Solutions is committed to delivering high-quality and timely services to its clients, ensuring their utmost satisfaction and success. With a clear focus on the pharmaceutical industry, LLX Solutions holds promise for investors seeking opportunities in this sector.
There is no investment information
No recent news or press coverage available for LLX Solutions LLC.